Global Health

The Ethics of Using Placebo Controls in Ebola Clinical Trials

Filed in Bioethics, Drugs & Devices, Global Health by on November 25, 2014 0 Comments
The Ethics of Using Placebo Controls in Ebola Clinical Trials
Share

By Carl H. Coleman Cross-Posted at Bill of Health With well over 5,000 global deaths from Ebola already reported, drug developers are working fast to begin human clinical trials of promising experimental treatments.  Earlier this month, US government officials announced plans to launch a study of multiple Ebola interventions at the NIH Clinical Center, Emory […]

Share

Continue Reading »

Do Healthcare Workers Have a Duty to Treat During a Pandemic?

Filed in Ethics, Global Health, Public Health by on November 13, 2014 0 Comments
Do Healthcare Workers Have a Duty to Treat During a Pandemic?
Share

By Donna Hanrahan The recent Ebola outbreak has reignited a longstanding debate in medical ethics – in times of a pandemic, do healthcare workers have a duty to treat? The global community was confronted with similar issues during the outbreak of SARS in 2003, a time when 30% of cases were attributed to healthcare workers […]

Share

Continue Reading »

WHO’s 2013 Global TB Update: Good News and Bad

Filed in Bioethics, Drugs & Devices, Global Health by on November 6, 2013 0 Comments
WHO’s 2013 Global TB Update: Good News and Bad
Share

At last week’s 44th Union World Conference on Lung Health in Paris, one of the main topics of discussion was the World Health Organization’s recently released 2013 Global Tuberculosis Report.  On the bright side, the report confirms a steady decline in the prevalence, incidence, and mortality of TB.  The world is on track to meet […]

Share

Continue Reading »

Sunder on Patents and Access to Medicine

Filed in Global Health by on September 30, 2012 0 Comments
Sunder on Patents and Access to Medicine
Share

Last week, the blog Concurring Opinions featured a symposium on Madhavi Sunder’s new book, From Goods to a Good Life: Intellectual Property and Global Justice. A chapter relevant to health law scholars is available online, here.  The chapter focuses on access to drugs in less developed countries (LDCs), and makes the following case: Not too long ago, an […]

Share

Continue Reading »

Kidney Sales, a Free-Market Approach

Filed in Global Health by on September 3, 2012 3 Comments
Share

Recent events in New Jersey have served to highlight deficiencies in the Kidney Market. The impoverished of the world, at present, freely considering their options in a market economy, have taken to selling their kidneys, valued at roughly $160,000 on the less than open market, to kidney brokers for the approximate sum of, give or […]

Share

Continue Reading »